Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis

被引:18
作者
Han, Susu [1 ]
Huang, Tao [2 ]
Li, Wen [1 ]
Liu, Shanshan [1 ]
Yang, Wei [1 ]
Shi, Qi [1 ]
Li, Hongjia [1 ]
Ren, Jianlin [1 ]
Hou, Fenggang [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, 274 Zhijiang Rd, Shanghai 200071, Peoples R China
[2] Affiliated Hosp Ningbo Univ, Ningbo, Zhejiang, Peoples R China
关键词
Hif-2; alpha; Expression; CRC; Prognosis; Tumor; NEWCASTLE-OTTAWA SCALE; PAS DOMAIN PROTEIN-1; POOR-PROGNOSIS; METAANALYSIS; STATISTICS; REVASCULARIZATION; FACTOR-1-ALPHA; SURVIVAL; PATHWAY; QUALITY;
D O I
10.1159/000491806
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: Although some studies showed that HIF-2 alpha expression was correlated with an unfavorable prognosis in colorectal cancer (CRC), the prognostic results remain conflicting in CRC. The present study was performed to evaluate the association between HIF-2 alpha expression and the clinicopathological features of this disease and to examine the potential prognostic role of HIF-2 alpha expression in CRC. Methods: Pooled odds ratios (ORs) or hazard ratios (HRs) were calculated from available publications, The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) datasets. Trial sequential analysis (TSA) was used to estimate the required sample information. Results: HIF-2 alpha protein expression was more frequent in CRC than in normal colonic tissues (OR = 150.49, P < 0.001), higher in male than female CRC patients (OR = 1.47, P = 0.008), and lower in high-grade than low-grade CRC (OR = 0.49, P = 0.029). TSA verified the reliability of the above results. HIF-2 alpha expression was not linked to the prognosis of CRC in overall survival (OS), disease-specific survival (DSS), metastasis-free survival, and relapse-free survival, and no significant correlation was found between HIF-2 alpha alteration and OS or disease-free survival (DFS) of CRC. Expression of both HIF-2 alpha and vascular endothelial growth factor (VEGFA, VEGFB, or VEGFC) was associated with a poor metastasis-free survival of CRC (HR = 6.95, HR = 113.51, and HR = 8.11, respectively). No association was observed between HIF-2 alpha expression and DFS in other cancers, but HIF-2 alpha expression was correlated with a worse DFS of CRC (HR = 1.23, P = 0.037). Moreover, HIF-2 alpha expression was linked to a good survival benefit in some cancers (B-cell lymphoma and lung adenocarcinoma: OS, multiple myeloma: DSS, breast cancer: distant metastasis-free survival, liposarcoma: distant recurrence-free survival) (all HRs < 1, Ps < 0.05). Conclusions: HIF-2 alpha expression may be associated with the carcinogenesis of CRC, which is higher in males than in females, negatively linked to tumor differentiation, and correlated with a worse DFS of CRC. Additional prospective studies are needed. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:516 / 527
页数:12
相关论文
共 57 条
[1]   SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015 [J].
Aranda, E. ;
Aparicio, J. ;
Alonso, V. ;
Garcia-Albeniz, X. ;
Garcia-Alfonso, P. ;
Salazar, R. ;
Valladares, M. ;
Vera, R. ;
Vieitez, J. M. ;
Garcia-Carbonero, R. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12) :972-981
[2]   Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients [J].
Athanasiou, T ;
Al-Ruzzeh, S ;
Kumar, P ;
Crossman, MC ;
Amrani, M ;
Pepper, JR ;
Del Stanbridge, R ;
Casula, R ;
Glenville, B .
ANNALS OF THORACIC SURGERY, 2004, 77 (02) :745-753
[3]   HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers [J].
Baba, Yoshifumi ;
Nosho, Katsuhiko ;
Shima, Kaori ;
Irahara, Natsumi ;
Chan, Andrew T. ;
Meyerhardt, Jeffrey A. ;
Chung, Daniel C. ;
Giovannucci, Edward L. ;
Fuchs, Charles S. ;
Ogino, Shuji .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (05) :2292-2301
[4]   Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma [J].
Bangoura, Gassimou ;
Liu, Zhi-Su ;
Qian, Qun ;
Jiang, Cong-Qing ;
Yang, Gui-Fan ;
Jing, Sun .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (23) :3176-3182
[5]   Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses [J].
Brok, Jesper ;
Thorlund, Kristian ;
Gluud, Christian ;
Wetterslev, Jorn .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (08) :763-769
[6]   The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data [J].
Cerami, Ethan ;
Gao, Jianjiong ;
Dogrusoz, Ugur ;
Gross, Benjamin E. ;
Sumer, Selcuk Onur ;
Aksoy, Buelent Arman ;
Jacobsen, Anders ;
Byrne, Caitlin J. ;
Heuer, Michael L. ;
Larsson, Erik ;
Antipin, Yevgeniy ;
Reva, Boris ;
Goldberg, Arthur P. ;
Sander, Chris ;
Schultz, Nikolaus .
CANCER DISCOVERY, 2012, 2 (05) :401-404
[7]  
Cleven AHG, 2007, CELL ONCOL, V29, P229
[8]   Random-effects model for meta-analysis of clinical trials: An update [J].
DerSimonian, Rebecca ;
Kacker, Raghu .
CONTEMPORARY CLINICAL TRIALS, 2007, 28 (02) :105-114
[9]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[10]   Meta-analysis methods for genome-wide association studies and beyond [J].
Evangelou, Evangelos ;
Ioannidis, John P. A. .
NATURE REVIEWS GENETICS, 2013, 14 (06) :379-389